(Q37069194)

18 August 2017

1 reference

title

Propofol-related infusion syndrome in intensive care patients (English)

1 reference

18 August 2017

1 reference

Stephanie Mallow Corbett

series ordinal

1

1 reference

18 August 2017

Isaac D Montoya

series ordinal

2

1 reference

18 August 2017

Frederick A Moore

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

28

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

250-258

1 reference

Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol-infusion syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Fatal myocardial failure associated with a propofol infusion in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lactic acidemia and bradyarrhythmia in a child sedated with propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Short-term propofol infusions in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Impaired fatty acid oxidation in propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lactic acidosis: an early marker of propofol infusion syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lacticacidosis after short‐term infusion of propofol for anaesthesia in a child with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Clinical management of cardiogenic shock associated with prolonged propofol infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Death after re-exposure to propofol in a 3-year-old child: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

A case of propofol toxicity: further evidence for a causal mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Fatal propofol infusion syndrome in association with ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion in children: when does an anesthetic tool become an intensive care liability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lactic acidosis following short-term propofol infusion may be an early warning of propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lactic acidosis associated with propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol-infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Long-term propofol infusion and cardiac failure in adult head-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Metabolic acidosis associated with a new formulation of propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome: an unusual cause of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Lactic acidosis during propofol-remifentanil anesthesia in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Metabolic acidosis associated with propofol in the absence of other causative factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome during anaesthesia for scoliosis surgery in an adolescent with neonatal progeroid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Rare but dangerous adverse effects of propofol and thiopental in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

The syndrome of irreversible acidosis after prolonged propofol infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

A case of suspected non-neurosurgical adult fatal propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Survival of propofol infusion syndrome in a head-injured patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol infusion syndrome--a fatal case at a low infusion rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

The propofol infusion syndrome treated with haemofiltration. Is there a time for genetic screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Too much of a good thing? Tracing the history of the propofol infusion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol as Used for Sedation in the ICU

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol vs midazolam for ICU sedation : a Canadian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol for sedation in the intensive care unit: essentials for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

The FDA Warning Against Prolonged Sedation With Propofol in Children Remains Warranted

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Influence of the anesthetic 2,6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.2.250

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.2.250

1 reference

18 August 2017

1 reference